Qiagen Nv Stock Alpha and Beta Analysis
| QGEN Stock | USD 47.01 0.52 1.12% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Qiagen NV. It also helps investors analyze the systematic and unsystematic risks associated with investing in Qiagen NV over a specified time horizon. Remember, high Qiagen NV's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Qiagen NV's market risk premium analysis include:
Beta 0.62 | Alpha (0.03) | Risk 1.29 | Sharpe Ratio 0.0085 | Expected Return 0.0109 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Qiagen NV Backtesting, Qiagen NV Valuation, Qiagen NV Correlation, Qiagen NV Hype Analysis, Qiagen NV Volatility, Qiagen NV History and analyze Qiagen NV Performance. Qiagen NV Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Qiagen NV market risk premium is the additional return an investor will receive from holding Qiagen NV long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Qiagen NV. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Qiagen NV's performance over market.| α | -0.03 | β | 0.62 |
Qiagen NV expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Qiagen NV's Buy-and-hold return. Our buy-and-hold chart shows how Qiagen NV performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Qiagen NV Market Price Analysis
Market price analysis indicators help investors to evaluate how Qiagen NV stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Qiagen NV shares will generate the highest return on investment. By understating and applying Qiagen NV stock market price indicators, traders can identify Qiagen NV position entry and exit signals to maximize returns.
| Price Series Summation | ||
| Price Series Division | ||
| Inverse Tangent Over Price Movement | ||
| Price Ceiling Movement | ||
| Aroon Oscillator | ||
| Balance Of Power | ||
| Parabolic SAR | ||
| MidPoint over period | ||
| Stalled Pattern | ||
| Separating Lines |
Qiagen NV Return and Market Media
The median price of Qiagen NV for the period between Thu, Oct 9, 2025 and Wed, Jan 7, 2026 is 46.33 with a coefficient of variation of 3.31. The daily time series for the period is distributed with a sample standard deviation of 1.53, arithmetic mean of 46.26, and mean deviation of 1.29. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Can Qiagen N.V. stock hit record highs again - Weekly Stock Summary High Conviction Buy Zone Picks - newser.com | 10/23/2025 |
2 | Qiagen Q3 Earnings Snapshot | 11/04/2025 |
3 | Volta Labs Delivers the Ultimate Whole Genome Sequencing Sample Prep Launch Callisto Now Unifies the Entire WGS Ecosystem on One Platform | 11/12/2025 |
4 | Segall Bryant Hamill LLC Acquires 15,082 Shares of Qiagen N.V. QGEN - MarketBeat | 11/25/2025 |
5 | GM Advisory Group LLC Takes Position in Qiagen N.V. QGEN | 11/28/2025 |
6 | American Century Companies Inc. Purchases 444,433 Shares of Qiagen N.V. QGEN - MarketBeat | 12/02/2025 |
7 | Qiagen Up 6.3 percent Since Last Earnings Report Can It Continue | 12/04/2025 |
8 | Companies Are Just Now Tallying Up the Impact of the US Shutdown | 12/11/2025 |
9 | PTA-PVR QIAGEN N.V. Release according to Article 40, Section 1 of the WpHG - TradingView Track All Markets | 12/15/2025 |
10 | Whole Genome and Exome Sequencing Market By Application, Organism and Product with Executive and Consultant Guides | 12/18/2025 |
11 | Qiagen Upgraded by Wall Street Zen to Buy Rating | 12/22/2025 |
About Qiagen NV Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Qiagen or other stocks. Alpha measures the amount that position in Qiagen NV has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2025 | 2026 (projected) | Dividend Yield | 0.0259 | 0.0182 | Price To Sales Ratio | 5.76 | 7.28 |
Qiagen NV Upcoming Company Events
As portrayed in its financial statements, the presentation of Qiagen NV's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Qiagen NV's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Qiagen NV's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Qiagen NV. Please utilize our Beneish M Score to check the likelihood of Qiagen NV's management manipulating its earnings.
| 6th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Qiagen NV
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Qiagen NV Backtesting, Qiagen NV Valuation, Qiagen NV Correlation, Qiagen NV Hype Analysis, Qiagen NV Volatility, Qiagen NV History and analyze Qiagen NV Performance. To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Qiagen NV technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.